Novel phage derived antimicrobials
At a glance
- Project leader : Prof. Dr. Steffi Lehmann
- Deputy of project leader : Prof. Dr. Lars Fieseler
- Project team : Dr. Lukas Neutsch
- Project status : ongoing
- Funding partner : Innosuisse (Innovationsprojekt / Projekt Nr. 104.969 IP-LS)
- Project partner : Micreos GmbH
- Contact person : Steffi Lehmann
Description
Novel, patentable bacteriophage-based precision antimicrobials are generated. To minimize the risk of failure at the pre-clinical stage, in vivo activity screening in zebrafish embryos is combined with process development, continuous evolution, and phage engineering during early stages of discovery.